Navigation Links
Viswanathan Anand Is To Be Avahan’s HIV-AIDS Ambassador in Indi

Avahan, India a foundation set up by the Bill and Melinda Gates Foundation, on Thursday announced Grandmaster Viswanathan Anand as its HIV-AIDS ambassador in India. // The officials said that Anand, in his new role, would raise awareness of the disease in the country. The official release said that Anand's desire to raise the visibility of India's HIV disease is a welcomed step in reducing the stigma and discrimination associated with it. They explained that besides targeting the general public, Anand would focus on mobilising the much-needed engagement by business and industry and NRIs. Anand, a native of Tamil Nadu also plans to engage himself on the ground activities there, which is also one of the states hit hardest by HIV. He said that it is important for all sectors of the society to join hands and work together to contain the disease. He stated that they hope to create a significant understanding and compassion through their campaign as they concentrate on removing the stigma attached to the disease and are able to bring a message of urgency and promise to the people of India.
'"/>




Page: 1

Related medicine news :

1. Chess Champion Anand to Champion HIV/AIDS for Avahan
2. Religiosity May Be Instrumental In Preventing The Spread Of HIV-AIDS
3. Female Condom – Confidom Launched in Indi
4. Diabetic Population – Highest in Indi
Post Your Comments:
Breaking Medicine Technology:ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 2ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 3ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 2For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 3UC Davis study highlights work life issues of female surgeons 52395 1UC Davis study highlights work life issues of female surgeons 52395 2Fecal incontinence and quality of life 52393 1Early rice harvests ease annual famine in Bangladesh 9316 1Early rice harvests ease annual famine in Bangladesh 9316 2